Flock, smart-money disclosures made readable

Flock, smart-money disclosures made readable

Show all 44 disclosures

ACQUIREDT+30
Cooke Julie
Neurocrine Biosciences Inc · NASDAQ
+3,587 sh
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Onyia Jude
Neurocrine Biosciences Inc · NASDAQ
−1,936 sh · $302.4K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Gano Kyle
Neurocrine Biosciences Inc · NASDAQ
−3,386 sh · $529.0K
Filed 15 Sept 2026SEC Form 4view source
ACQUIREDT+30
Lippoldt Darin
Neurocrine Biosciences Inc · NASDAQ
+4,483 sh
Filed 15 Sept 2026SEC Form 4view source
ACQUIREDT+30
Onyia Jude
Neurocrine Biosciences Inc · NASDAQ
+3,587 sh
Filed 15 Sept 2026SEC Form 4view source
ACQUIREDT+30
Gano Kyle
Neurocrine Biosciences Inc · NASDAQ
+6,275 sh
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Abernethy Matt
Neurocrine Biosciences Inc · NASDAQ
−2,311 sh · $363.3K
Filed 15 Sept 2026SEC Form 4view source
ACQUIREDT+30
Keswani Sanjay Chandru
Neurocrine Biosciences Inc · NASDAQ
+3,914 sh
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Boyer David W.
Neurocrine Biosciences Inc · NASDAQ
−826 sh · $130.1K
Filed 15 Sept 2026SEC Form 4view source
ACQUIREDT+30
Benevich Eric
Neurocrine Biosciences Inc · NASDAQ
+6,275 sh
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Keswani Sanjay Chandru
Neurocrine Biosciences Inc · NASDAQ
−2,112 sh · $329.9K
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Delaet Ingrid
Neurocrine Biosciences Inc · NASDAQ
−2,419 sh · $377.9K
Filed 15 Sept 2026SEC Form 4view source
ACQUIREDT+30
Gorman Kevin Charles
Neurocrine Biosciences Inc · NASDAQ
+14,343 sh
Filed 15 Sept 2026SEC Form 4view source
REDUCEDT+30
Abernethy Matt
Neurocrine Biosciences Inc · NASDAQ
−2,709 sh · $423.2K
Filed 15 Sept 2026SEC Form 4view source
ACQUIREDStale
Benevich Eric
Neurocrine Biosciences Inc · NASDAQ
+3,194 sh · $138.1K
Filed 10 Sept 2026SEC Form 4view source
REDUCEDStale
Benevich Eric
Neurocrine Biosciences Inc · NASDAQ
−2,154 sh · $333.0K
Filed 10 Sept 2026SEC Form 4view source
REDUCEDStale
Sherwin Stephen A
Neurocrine Biosciences Inc · NASDAQ
−1,000 sh
Filed 3 Sept 2026SEC Form 4view source
DISCLOSEDQuarterly
Renaissance Technologies
Neurocrine Biosciences Inc · NASDAQ
2,335,897 sh · $393.7M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Dodge & Cox
Neurocrine Biosciences Inc · NASDAQ
5,584,707 sh · $941.2M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Two Sigma Investments
Neurocrine Biosciences Inc · NASDAQ
2,076,260 sh · $349.9M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Bridgewater Associates
Neurocrine Biosciences Inc · NASDAQ
205,677 sh · $34.7M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Neurocrine Biosciences Inc · NASDAQ
2,418,897 sh · $318.7M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Dodge & Cox
Neurocrine Biosciences Inc · NASDAQ
5,461,037 sh · $719.4M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Bridgewater Associates
Neurocrine Biosciences Inc · NASDAQ
148,141 sh · $19.5M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Neurocrine Biosciences Inc · NASDAQ
3,060,570 sh · $403.2M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Bridgewater Associates
Neurocrine Biosciences Inc · NASDAQ
149,990 sh · $21.3M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Neurocrine Biosciences Inc · NASDAQ
2,238,797 sh · $317.5M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Dodge & Cox
Neurocrine Biosciences Inc · NASDAQ
5,508,042 sh · $781.2M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Neurocrine Biosciences Inc · NASDAQ
984,811 sh · $139.7M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Dodge & Cox
Neurocrine Biosciences Inc · NASDAQ
5,556,618 sh · $780.0M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Neurocrine Biosciences Inc · NASDAQ
2,418,297 sh · $339.5M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
Dodge & Cox
Neurocrine Biosciences Inc · NASDAQ
5,566,814 sh · $699.7M
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Neurocrine Biosciences Inc · NASDAQ
2,366,397 sh · $297.4M
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Neurocrine Biosciences Inc · NASDAQ
14,190,708 sh · $1.95B
Filed 30 Jun 2024SEC 13Fview source